अApnaFunda

PRIVI SPECIALITY CHEMICALS LTD (PRIVISCL)

Process Industries · Chemicals: Major Diversified · figures to Nov '26

Quality scoreHow the business itself ranks against its sector peers on profitability, 3-year growth and leverage. 50 is the middle of the sector.71 / 100
Profitability 87Growth 92Balance sheet 32
Momentum scoreHow strong the recent trend is: 3-month price change, 12-month improvement in earnings and the rise in FII + DII holding, among companies above ₹500 cr.63 / 100
Price 57Earnings 69

Passes these screensQuality CompounderConsistent compounders

Share price

Closing priceAdjusted for splits and bonus issues.

₹3,491.9 latest close · −5.5% over the last 90 sessions

₹3,200₹3,400₹3,600Jul 3Jul 29Aug 24Sep 17Oct 14Nov 9 ₹3,200₹3,400₹3,600Jul 3Sep 4Nov 9

₹3,491.9 month-end · +10.7% over 12 months

₹3,000₹3,500Nov '25Jan '26Apr '26Jun '26Sep '26Nov '26 ₹3,000₹3,500Nov '25May '26Nov '26

₹3,491.9 month-end · +173.9% over 3 years

₹1,000₹2,000₹3,000Nov '23Jun '24Jan '25Sep '25Apr '26Nov '26 ₹1,000₹2,000₹3,000Nov '23May '25Nov '26

₹3,491.9 month-end · +6983699.8% since Jan '19

₹0₹2,000₹4,000Jan '19Aug '20Mar '22Sep '23Apr '25Nov '26 ₹0₹2,000₹4,000Jan '19Dec '22Nov '26

52-week range ₹2570.80 to ₹3785.30 · 1-year volatility 33.8%

Was the rally earned?

+11%share price, 1 yearLower P/E held it back

Mostly yes, with a catch.

  • Per-share earnings added 50 points, but investors now pay less per rupee of profit (P/E 56.7x to 39.0x), which took 39 points back.
  • The share count rose 3%.
Net profit growth: +53 pts. Points of the price return explained by net profit growing (or shrinking).+53 ptsNet profit growthP/E change: −39 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−39 ptsP/E changeShare count change: −3 pts. Points of the price return explained by the share count changing. More shares count against the price.−3 ptsShare count changeShare price: +11%+11%Share priceNet profit growth: +53 pts. Points of the price return explained by net profit growing (or shrinking).+53ProfitP/E change: −39 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−39P/EShare count change: −3 pts. Points of the price return explained by the share count changing. More shares count against the price.−3SharesShare price: +11%+11%Share price
Net profit growth+53 ptsNet profit rose about 66%, which lifts the price.
P/E change-39 ptsThe P/E fell from 56.7x to 39.0x, which lowers the price.
Share count change-3 ptsShare count rose 3%, which lowers the price.
+174%share price, 3 yearsLower P/E held it back

Mostly yes, with a catch.

  • Per-share earnings added 476 points, but investors now pay less per rupee of profit (P/E 224.4x to 39.0x), which took 302 points back.
  • The share count rose 6%.
Net profit growth: +485 pts. Points of the price return explained by net profit growing (or shrinking).+485 ptsNet profit growthP/E change: −302 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−302 ptsP/E changeShare count change: −9 pts. Points of the price return explained by the share count changing. More shares count against the price.−9 ptsShare count changeShare price: +174%+174%Share priceNet profit growth: +485 pts. Points of the price return explained by net profit growing (or shrinking).+485ProfitP/E change: −302 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−302P/EShare count change: −9 pts. Points of the price return explained by the share count changing. More shares count against the price.−9SharesShare price: +174%+174%Share price
Net profit growth+485 ptsNet profit rose about 1565%, which lifts the price.
P/E change-302 ptsThe P/E fell from 224.4x to 39.0x, which lowers the price.
Share count change-9 ptsShare count rose 6%, which lowers the price.
+112%share price, 5 yearsLower P/E held it back

Mostly yes, with a catch.

  • Per-share earnings added 163 points, but investors now pay less per rupee of profit (P/E 55.0x to 39.0x), which took 51 points back.
  • The share count barely moved.
Net profit growth: +163 pts. Points of the price return explained by net profit growing (or shrinking).+163 ptsNet profit growthP/E change: −51 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−51 ptsP/E changeShare count change: 0 pts. Points of the price return explained by the share count changing. More shares count against the price.0 ptsShare count changeShare price: +112%+112%Share priceNet profit growth: +163 pts. Points of the price return explained by net profit growing (or shrinking).+163ProfitP/E change: −51 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−51P/EShare count change: 0 pts. Points of the price return explained by the share count changing. More shares count against the price.0SharesShare price: +112%+112%Share price
Net profit growth+163 ptsNet profit rose about 199%, which lifts the price.
P/E change-51 ptsThe P/E fell from 55.0x to 39.0x, which lowers the price.
Share count change0 ptsShare count was little changed. More shares would count against the price.
What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with AETHER INDUSTRIES

How rough has the ride been?

Maximum drawdown-66.7%recovered 2020-07
1-year volatility33.8%annualised
Beta vs sector index0.763-year daily, correlation 0.35
Volume spikes3last 90 sessions, 5x the 50-day median

Drawdown from peak

0%−20%−40%−60%2020202120222023202420252026−59.1% 0%−20%−40%−60%2020202220242026−59.1%
Largest drawdowns

-66.7% (2020-03 peak to 2020-03 low, recovered 2020-07)

-60.7% (2022-01 peak to 2023-02 low, recovered 2025-05)

-50.0% (2019-02 peak to 2019-02 low, recovered 2019-02)

Most recent volume spikes

2026-10-29: 7.4x the 50-day median, price -5.2% that day

2026-09-29: 6.7x the 50-day median, price 0.0% that day

2026-07-30: 6.9x the 50-day median, price -3.6% that day

Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).

Is it expensive against its own past and its peers?

39.0xP/E todayNear its historic low
Against its own history20th percentile
CheapestMedian 50.1xDearest

Usual range 19.3x to 204.3x since 2019-01.

Against Process Industries39.0x vs 18.1x
This company
39.0x
Sector median
18.1x

116% above the Process Industries median.

6.8x79.3x151.9x224.4xJan '19Aug '20Mar '22Oct '23May '25Nov '266.8x79.3x151.9x224.4xJan '19Sep '21May '24Nov '26
P/E (this company)10th to 90th percentile of its own historyIts medianProcess Industries median

The chart loads when you open this tab.

P/B (this company)10th to 90th percentile of its own historyIts medianProcess Industries median

The chart loads when you open this tab.

P/S (this company)10th to 90th percentile of its own historyIts medianProcess Industries median
How to read this

Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).

Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.

All terms explained in the glossary →

How Process Industries is valued

Where does it rank among Process Industries peers?

Each cell is the company's percentile rank among its Process Industries peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

Where it ranks today

  • ROCE86th▲ 16 pts vs a year ago
  • Op. margin88th▼ 4 pts vs a year ago
  • Revenue growth80thflat vs a year ago
  • EPS growth81st▼ 5 pts vs a year ago
  • Debt/equity ↓27th▲ 12 pts vs a year ago
  • Cash cycle ↓29th▲ 9 pts vs a year ago
  • P/E ↓19th▲ 3 pts vs a year ago
  • 12M momentum72nd▼ 23 pts vs a year ago

Rank history

ROCE
Op. margin
Revenue growth
EPS growth
Debt/equity ↓
Cash cycle ↓
P/E ↓
12M momentum
Dec '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '26Nov '26
Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Process Industries sector page Watch it move against Process Industries in the Observatory

What is the price implying?

~34%annual earnings growth implied by the priceAbove delivered growth

At normalised P/E (five-year average earnings) of 93.3x, a holder earning 12%/yr needs earnings to grow about 34.1%/yr for 10 years, then trade at 15x.

Delivered19.1%/yrEPS, last 10 fiscal years · 3-yr avg to 3-yr avg
Gap+15.1 ptsimplied minus delivered
Rank226thmost demanding of 856

Over time

Implied growth by month (solid) and delivered growth (dashed).

0%19%38% Mar 2020Nov 2026 0%19%38% Mar 2020Nov 2026

Change the assumptions

Exit P/E / return11%12%13%
12x35.9%37.1%38.3%
15x32.9%34.1%35.3%
20x29.2%30.4%31.5%

Drag a slider to test other assumptions

Implied: 34.1%/yr

Looking back

  • Jan 2021Price implied 20%/yr; EPS has since grown 10%/yr (6.0 yrs)
  • Jan 2022Price implied 33%/yr; EPS has since grown 22%/yr (5.0 yrs)

Past comparisons cover only companies listed today (survivorship bias) and say nothing about future outcomes.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect. How this is calculated and the market-wide lists.

What prices imply across Process Industries The market-wide Expectations lists

Key figures

Share Priceclose 9 Nov
₹3491.90
P/E
39.0x
ROCE
22.0%
Market Cap
₹13641 cr
Revenue (TTM)
₹2672 cr
P/S
5.1x
P/B
9.7x
ROE
24.8%
Operating Margin
23.0%
Debt / Equity
0.7x
Promoter Holding
60.6%
12M Momentum
10.7%

52-week range

₹2570.80₹3785.30
76% of the way from its 52-week low to its high

Price risk

1Y volatility
33.8%
Beta vs sector
1-year daily
0.52

Balance sheet & cash

Interest cover
operating profit ÷ interest
7.3x
Cash from profit, 3Y
operating cash flow ÷ net profit
1.98x
Share count, 1Y
unchanged

Are profits backed by cash?

5 of 7checks within range2 near a threshold
Other income reliance6%Within range

Other income as a share of pre-tax profit (trailing twelve months): 5.5%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate27%Within range

Median quarterly effective tax rate over about 2.5 years: 27.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion1.98xWithin range

Operating cash flow divided by net profit over the last three fiscal years: 1.98x (cash from operations ₹1,185 cr, net profit ₹597 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow2 of 5 yrsNear threshold

Fiscal years with positive free cash flow in the last 5: 2. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history+7 daysWithin range

Debtor days are above the median of the previous three fiscal years by 7 days (75 vs 68). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress27% of fixed assetsWithin range

Capital work-in-progress is 27% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days+45 days / 2 yrsNear threshold

Days payable changed by +45 over two years. Bands: rise of up to 30 days; more than 30 days.

Tap a check to see how it is measured

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

  • Over 2 years, promoters trimmed 13.4 pts; DIIs added 6.7 pts; FIIs added 1.0 pts.
  • The number of shareholders rose from 17,702 to 44,875 (+154%) between Dec 2023 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupDec '23Jun '26Change
Promoters74.0%60.6%-13.4 pts
FIIs1.0%1.9%+1.0 pts
DIIs3.4%10.1%+6.7 pts
Public and others21.6%27.4%+5.8 pts

Number of shareholders

44,875shareholders+154% since Dec '23
16k26k35k45k Dec '23Jun '24Dec '24Jun '25Dec '25Jun '26
Dec '23: 17,702
Mar '24: 16,821
Jun '24: 17,029
Sep '24: 16,372
Dec '24: 18,131
Mar '25: 16,721
Jun '25: 28,685
Sep '25: 28,203
Dec '25: 32,016
Mar '26: 34,415
Jun '26: 44,875
16k26k35k45k Dec '23Dec '24Dec '25Jun '26
Dec '23: 17,702
Mar '24: 16,821
Jun '24: 17,029
Sep '24: 16,372
Dec '24: 18,131
Mar '25: 16,721
Jun '25: 28,685
Sep '25: 28,203
Dec '25: 32,016
Mar '26: 34,415
Jun '26: 44,875

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

What happened next to similar setups

−7.7%typical 12-month return vs the marketBelow the base rate
  • We found 50 past situations where a non-financial company looked like PRIVI SPECIALITY CHEMICALS LTD today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
  • Over the following 12 months the middle half of them returned −18% to +14% vs the market, against −2% for all non-financial companies in the same months.
  • The analogs' median sat below that base rate (gap −5.4%, 80% range −12.0% to −1.2%), but the matches cluster in only 6 distinct 12-month windows.

Where the 50 outcomes landed

−60%−40%−20%0%+20%+40%+60%+80%
RKFORGE · Sep 2024: −42.0% vs market
VRLLOG · Mar 2023: −41.4% vs market
PVRINOX · Mar 2020: −41.3% vs market
ASTERDM · Feb 2020: −35.2% vs market
BLUEDART · Aug 2022: −32.8% vs market
GREENLAM · Jan 2020: −32.6% vs market
JKCEMENT · Mar 2021: −32.1% vs market
BECTORFOOD · Oct 2024: −30.9% vs market
SFL · Feb 2022: −30.8% vs market
GUFICBIO · Dec 2024: −30.1% vs market
SUPRAJIT · Nov 2021: −23.3% vs market
REDTAPE · Sep 2024: −20.4% vs market
ELGIEQUIP · Jan 2024: −18.6% vs market
SUDARSCHEM · Sep 2020: −17.0% vs market
KPRMILL · Oct 2023: −16.7% vs market
METROBRAND · Jan 2025: −16.4% vs market
INDGN · May 2025: −15.0% vs market
JLHL · Oct 2025: −14.5% vs market
KIMS · Aug 2023: −14.0% vs market
ASAHIINDIA · Feb 2020: −13.0% vs market
HEIDELBERG · May 2020: −11.5% vs market
TEGA · Apr 2024: −11.2% vs market
CRAFTSMAN · Mar 2023: −10.8% vs market
MANKIND · Aug 2025: −9.1% vs market
SUNDRMFAST · Jan 2020: −8.4% vs market
LUXIND · Jan 2020: −7.0% vs market
CCL · Jun 2020: −5.7% vs market
EPL · Jun 2020: −4.8% vs market
JBCHEPHARM · Dec 2023: −3.7% vs market
BHARATFORG · Jan 2020: −0.1% vs market
MEDANTA · Jul 2025: +1.7% vs market
RAINBOW · Dec 2023: +6.9% vs market
ROLEXRINGS · Aug 2022: +7.4% vs market
KNRCON · Mar 2021: +7.8% vs market
VMART · Dec 2020: +8.8% vs market
APLAPOLLO · May 2022: +11.0% vs market
UNOMINDA · Feb 2020: +11.5% vs market
AARTIIND · Nov 2020: +15.0% vs market
GLENMARK · Aug 2025: +19.7% vs market
EMCURE · Aug 2025: +23.6% vs market
APLLTD · Jan 2020: +26.9% vs market
NH · Jun 2022: +30.8% vs market
RADICO · Aug 2020: +36.6% vs market
MOLDTKPAC · Apr 2021: +40.2% vs market
ASTEC · Mar 2020: +43.8% vs market
SOLARINDS · Oct 2021: +51.2% vs market
POLYMED · Jan 2020: +56.2% vs market
SRF · Aug 2020: +57.1% vs market
BLUESTARCO · Mar 2024: +61.9% vs market
ASTRAMICRO · Jun 2025: +69.4% vs market
Similar setups −7.7%All companies −2.3%← worse than the marketbetter than the market →

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months

Similar setups' median
−7.7%
All companies' median
−2.3%
Beat the market
40% vs 48%

50 past situations · 50 companies · 33 months · 2020–2025

The closest matches

CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
NH
Health Services
Jun 2022 38x25% +29%−17% +31%
JKCEMENT
Non-Energy Minerals
Mar 2021 45x17% +210%−2% −32%
RAINBOW
Health Services
Dec 2023 57x24% +61%0% +7%
KIMS
Health Services
Aug 2023 48x24% +66%0% −14%
AARTIIND
Process Industries
Nov 2020 38x15% +37%−2% +15%
Show the other 3 matches
CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
BLUEDART
Transportation
Aug 2022 53x31% +46%−5% −33%
CCL
Consumer Non-Durables
Jun 2020 19x18% −8%−9% −6%
GUFICBIO
Health Technology
Dec 2024 54x— +44%−6% −30%
How reliable is this?

Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: 12-month momentum, drawdown from 12-month high and P/E. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to PRIVI SPECIALITY CHEMICALS LTD. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-11-09. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

FeatureWeightNon-financialFinancial
P/E1yesyes
P/S1yes—
P/B1—yes
ROCE1yes—
operating margin1yes—
ROE1—yes
debt/equity0.75yes—
interest cover0.5yes—
revenue growth0.75yesyes
12-month momentum1yesyes
drawdown from 12-month high0.75yesyes
size0.75yesyes
volatility0.5yesyes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

  • One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
  • Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
  • Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
  • Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
  • Pools: non-financial: 98,395 company-months from 2019 companies; financial: 5,659 company-months from 108 companies. 2349 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

Consumer Services
68%similar
revenuedebt/equity
Finance
64%similar
volatilitymarket cap
Health Technology
62%similar
P/Evolatility
Finance
60%similar
P/EROCE
Consumer Non-Durables
60%similar
ROCEoperating margin
Process Industries
56%similar
P/Erevenue
Process Industries
52%similar
P/Edebt/equity
Process Industries
51%similar
ROCEP/E

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What changed?

30 events since Dec '22

  1. OctPriceVolume reached 7.4x its 50-day median on 2026-10-29; price -5.2% that day.
  2. JulPriceVolume reached 6.9x its 50-day median on 2026-07-30; price -3.6% that day.
  3. JunInstitutionsFII + DII holding rose 6.2 pts over 2 quarters to 12.0%.
  4. JunPeer rankMoved into the top quartile of Process Industries on ROCE (from the 2nd quartile).
  5. JunDebtDebt / equity fell below 1.0x (0.72x).
  6. MayPriceVolume reached 5.8x its 50-day median on 2026-05-11; price -0.4% that day.
  7. MarPromoterPromoter holding fell 9.3 pts to 60.6%.
  8. JanPriceVolume reached 8.3x its 50-day median on 2026-01-06; price -3.3% that day.
Show 22 earlier events
  1. DecPriceVolume reached 104.2x its 50-day median on 2025-12-31; price -12.1% that day.
  2. SepPromoterPromoter holding fell 4.2 pts to 69.9%.
  3. SepInstitutionsFII + DII holding rose 3.0 pts over 1 quarter to 5.4%.
  4. AugPriceVolume reached 7.8x its 50-day median on 2025-08-01; price -4.0% that day.
  5. MayPriceRegained the 2022-01 peak, 27 months after the low.
  6. MayPriceVolume reached 21.1x its 50-day median on 2025-05-08; price +8.3% that day.
  7. OctPriceVolume reached 8.6x its 50-day median on 2024-10-18; price +4.2% that day.
  8. JulPriceVolume reached 7.3x its 50-day median on 2024-07-29; price -0.6% that day.
  9. JunResultsYear-on-year EPS growth turned positive.
  10. JunPeer rankMoved into the 2nd quartile of Process Industries on ROCE (from the bottom quartile).
  11. JunDividendStarted paying a dividend (payout 8% of profit).
  12. MayPriceVolume reached 10.4x its 50-day median on 2024-05-02; price +5.4% that day.
  13. AprValuationP/E crossed above the 90th percentile of its own history to date (221.0x).
  14. JanPriceVolume reached 8.8x its 50-day median on 2024-01-23; price +1.7% that day.
  15. NovPriceVolume reached 11.1x its 50-day median on 2023-11-06; price +5.3% that day.
  16. JunValuationP/E crossed above the 90th percentile of its own history to date (190.2x).
  17. JunDividendDividend payout cut from 8% to 0% of profit.
  18. MarPriceVolume reached 72.5x its 50-day median on 2023-03-09; price +1.3% that day.
  19. FebPriceFell 61% from the Jan 2022 peak to the Feb 2023 low.
  20. FebPeer rankSlipped to the bottom quartile of Process Industries on ROCE (from the 3rd quartile).
  21. DecPeer rankMoved into the 3rd quartile of Process Industries on ROCE (from the bottom quartile).
  22. DecPriceVolume reached 12.8x its 50-day median on 2022-12-27; price +8.0% that day.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Monthly history60 months · 2021-12 to 2026-11
MonthP/ERevenue (TTM)ROEROCEDebt / Equity
2026-1139.0x₹2672 cr24.8%22.0%0.7x
2026-1036.0x₹2672 cr24.2%22.0%0.7x
2026-0940.1x₹2672 cr24.2%22.0%0.7x
2026-0841.5x₹2565 cr22.5%22.0%0.7x
2026-0743.2x₹2565 cr22.5%22.0%0.7x
2026-0643.8x₹2565 cr22.5%22.0%0.7x
2026-0542.4x₹2457 cr26.0%16.0%1.0x
2026-0443.7x₹2457 cr26.0%16.0%1.0x
2026-0337.7x₹2457 cr26.0%16.0%1.0x
2026-0244.5x₹2343 cr23.2%16.0%1.0x
2026-0141.2x₹2343 cr23.2%16.0%1.0x
2025-1241.1x₹2343 cr23.2%16.0%1.0x
2025-1156.7x₹2197 cr19.1%16.0%1.0x
2025-1052.2x₹2197 cr19.1%16.0%1.0x
2025-0942.9x₹2197 cr19.1%16.0%1.0x
2025-0846.3x₹2102 cr16.7%16.0%1.0x
2025-0753.4x₹2102 cr16.7%16.0%1.0x
2025-0647.5x₹2102 cr16.7%16.0%1.0x
2025-0559.6x₹1972 cr16.5%12.0%1.1x
2025-0450.9x₹1972 cr16.5%12.0%1.1x
2025-0344.0x₹1972 cr16.5%12.0%1.1x
2025-0242.2x₹1885 cr14.8%12.0%1.1x
2025-0150.4x₹1885 cr14.8%12.0%1.1x
2024-1250.7x₹1885 cr14.8%12.0%1.1x
2024-1161.3x₹1807 cr13.2%12.0%1.1x
2024-1055.5x₹1807 cr13.2%12.0%1.1x
2024-0947.3x₹1807 cr13.2%12.0%1.1x
2024-0860.6x₹1752 cr10.3%12.0%1.1x
2024-0765.8x₹1752 cr10.3%12.0%1.1x
2024-0659.6x₹1752 cr10.3%12.0%1.1x
2024-05205.8x₹1608 cr2.5%6.0%1.3x
2024-04221.0x₹1608 cr2.5%6.0%1.3x
2024-03174.5x₹1608 cr2.5%6.0%1.3x
2024-02206.9x₹1608 cr2.5%6.0%1.3x
2024-01216.0x₹1608 cr2.5%6.0%1.3x
2023-12207.1x₹1608 cr2.5%6.0%1.3x
2023-11224.4x₹1608 cr2.5%6.0%1.3x
2023-10216.3x₹1608 cr2.5%6.0%1.3x
2023-09214.4x₹1608 cr2.5%6.0%1.3x
2023-08202.8x₹1608 cr2.5%6.0%1.3x
2023-07193.1x₹1608 cr2.5%6.0%1.3x
2023-06190.2x₹1608 cr2.5%6.0%1.3x
2023-0544.8x₹1404 cr11.9%10.0%1.1x
2023-0442.9x₹1404 cr11.9%10.0%1.1x
2023-0342.2x₹1404 cr11.9%10.0%1.1x
2023-0237.5x₹1404 cr11.9%10.0%1.1x
2023-0140.1x₹1404 cr11.9%10.0%1.1x
2022-1245.9x₹1404 cr11.9%10.0%1.1x
2022-1150.3x₹1404 cr11.9%10.0%1.1x
2022-1052.8x₹1404 cr11.9%10.0%1.1x
2022-0958.2x₹1404 cr11.9%10.0%1.1x
2022-0855.9x₹1404 cr11.9%10.0%1.1x
2022-0750.0x₹1404 cr11.9%10.0%1.1x
2022-0643.6x₹1404 cr11.9%10.0%1.1x
2022-0539.0x₹1277 cr16.2%12.0%0.7x
2022-0465.3x₹1277 cr16.2%12.0%0.7x
2022-0362.7x₹1277 cr16.2%12.0%0.7x
2022-0262.6x₹1277 cr16.2%12.0%0.7x
2022-0167.8x₹1277 cr16.2%12.0%0.7x
2021-1260.8x₹1277 cr16.2%12.0%0.7x

Older months are in the live observatory.

Methodology and data notes

Methodology

Methodology and data notes

All figures come from public exchange prices and screener.in financial statements. Quarterly and annual results are shown from 60 days after the period end, so a month never uses a result before it would plausibly have been published. Statements are the latest versions, which may include later restatements.

Sector medians, percentiles and indices use today's listed companies in the sector (survivorship bias). Prices are adjusted for splits and bonus issues; around a corporate action the fundamentals may lag the price by up to a month, and affected sections are hidden.

The return decomposition uses price = P/E × net profit ÷ share count. The reverse DCF uses a fixed 12% cost of equity, a 10-year horizon and a 15x terminal P/E, and is an illustration only. Events, flags and twins follow fixed rules and thresholds described next to each section.

Feedback